YTRACIS, radiopharmaceutical precursor, as a solution bottle
Active ingredients: Yttrium chloride y-90
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Radiopharmaceutical precursor as a solutionbottlevoie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- YTRACIS, précurseur radiopharmaceutique, en solution
- Pharmaceutical form
- précurseur radiopharmaceutique en solution
- Route of administration
- voie extracorporelle autre
- Presentation description
- 1 flacon(s) en verre de 0,925 à 3,7 GBq
- Marketing authorisation holder
- CIS BIO INTERNATIONAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Dec 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65491383CIP75649159CIP133400956491599Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORURE D'YTTRIUM [90Y]solution | 1,850 Gbq à la date de calibration · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.